Evidence map›Paper›PMID 40933621›Full record

ArticleThe mental health clinician2025

A primary care psychiatric pharmacist clinic for addressing hypertension and mental health disparities in black patients.

Stephanie L Hsia, Shirley Wong

Abstract read
In one paragraph

Article in The mental health clinician, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephanie L Hsia(Corresponding author) Associate Professor of Clinical Pharmacy, University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, Los Angeles, California, shsia@usc.edu.ORCID https://orcid.org/0000-0001-7377-9842
Shirley WongAssociate Professor of Clinical Pharmacy, University of California, San Francisco School of Pharmacy, San Francisco, California.ORCID https://orcid.org/0009-0000-0371-8112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A psychiatric pharmacist can play a critical role in addressing health disparities in black patients by managing both psychiatric and nonpsychiatric conditions. Black patients experience disparities in the treatment of both hypertension and mental health disorders, highlighting the need for innovative care models. This paper describes the integration of a psychiatric pharmacist into a primary care clinic to provide comprehensive medication management for hypertension, psychiatric disorders, and tobacco use disorder in black patients. The integration of this model faced challenges, including limited pharmacist funding and provider unfamiliarity with the psychiatric pharmacist's role. We describe how these barriers can be mitigated through relationship-building and demonstrating the pharmacist's value in patient care. This model highlights the potential for psychiatric pharmacists to provide whole-person care, addressing both psychiatric and nonpsychiatric conditions and working to reduce health disparities. The implementation of psychiatric pharmacists in primary care settings may serve as a strategy to improve equitable health care access and outcomes for black patients.

Indexed as

black Americanshealth disparitieshealth equityhypertensionmental healthpsychiatric pharmacy

Identifiers

PMID40933621
PMCPMC12418767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.